Three Thiol Groups Are Important for the Activity of the Liver Microsomal Glucose-6-phosphatase System
UNUSUAL BEHAVIOR OF ONE THIOL LOCATED IN THE GLUCOSE-6-PHOSPHATE TRANSLOCASE*

Eric Clottes and Ann BurchellDagger

From the Department of Obstetrics and Gynaecology, Ninewells Hospital and Medical School, Dundee University, Dundee, DD1 9SY, Scotland

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Liver microsomal glucose-6-phosphatase (Glc-6-Pase) is a multicomponent system involving both substrate and product carriers and a catalytic subunit. We have investigated the inhibitory effect of N-ethylmaleimide (NEM), a rather specific sulfhydryl reagent, on rat liver Glc-6-Pase activity. Three thiol groups are important for Glc-6-Pase system activity. Two of them are located in the glucose-6-phosphate (Glc-6-P) translocase, and one is located in the catalytic subunit. The other transporters (phosphate and glucose) are not affected by NEM treatment. The NEM alkylation of the catalytic subunit sulfhydryl residue is prevented by preincubating the disrupted microsomes with saturating concentrations of substrate or product. This suggests either that the modified cysteine is located in the protein active site or that substrate binding hides the thiol group via a conformational change in the enzyme structure. Two other thiols important for the Glc-6-Pase system activity are located in the Glc-6-P translocase and are more reactive than the one located in the catalytic subunit. The study of the NEM inhibition of the translocase has provided evidence of the existence of two distinct areas in the protein that can behave independently, with conformational changes occurring during Glc-6-P binding to the transporter. The recent cloning of a human putative Glc-6-P carrier exhibiting homologies with bacterial phosphoester transporters, such as Escherichia coli UhpT (a Glc-6-P translocase), is compatible with the fact that two cysteine residues are important for the bacterial Glc-6-P transport.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The strategic position of Glc-6-Pase1 (EC 3.1.3.9) in carbohydrate metabolism, at the connection between gluconeogenesis and glycogenolysis, makes it a key enzyme in blood glucose homeostasis (1). The enzyme is a nonspecific phosphohydrolase tightly associated with the endoplasmic reticulum and nuclear membranes of liver and kidney cells (1). It has been identified as a 38-kDa protein (2, 3) and has been cloned in several animal species (4-7).2 The active site of the enzyme is located in the endoplasmic reticulum lumen (8). In vitro, with the use of microsomes (small endoplasmic reticulum vesicles), the protein activity exhibits a phenomenon termed latency, with part of its activity expressed only when the membrane is disrupted, increasing both activity and affinity (9). To explain the role of the membrane in the function of Glc-6-Pase, two models have been proposed, the conformational model (10, 11) and the transport model (12, 13).

The conformational model (10, 11, 14-18) explains all of the kinetic observations by assuming that the protein can be found in several active conformations, each one possessing particular properties. The transport model involves specific permeases termed T1 (Glc-6-P), T2 (phosphate), and T3 (glucose). These carriers allow the translocation of the substrate molecules (Glc-6-P) through the membrane into the endoplasmic reticulum lumen, followed by its hydrolysis by the Glc-6-Pase catalytic subunit and then the elimination of the reaction products (phosphate and Glc) from the endoplasmic reticulum cisternae (Fig. 1; for review see Ref. 19). However, direct evidence, such as the unequivocal identification of one of the transporters, has to be produced. Recently, an elegant study using a very specific Glc-6-Pase inhibitor has provided compelling evidence for the existence of T1 (20). The first indications for the existence of such a Glc-6-P translocase were provided using chemical modification of thiol groups of the Glc-6-Pase system. Although the presence of an accessible sulfhydryl residue(s) necessary for the transport activity of the Glc-6-P translocase T1 is clearly established (21-24), the number of such residues is still to be elucidated. The difficulty with determining this is that the catalytic subunit can also be inhibited by thiol reagents (25, 11).


View larger version (68K):
[in this window]
[in a new window]
 
Fig. 1.   Schematic diagram of the microsomal Glc-6-Pase transport model. The Glc-6-P, phosphate (Pi), and Glc carriers are termed T1, T2, and T3, respectively. SP denotes stabilizing protein.

In this paper, we demonstrate that two thiol groups of the Glc-6-P translocase and one in the Glc-6-Pase catalytic subunit are important for the activity of the system. We also show that conformational changes in the translocase protein are triggered by Glc-6-P binding.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Chemicals-- Glc-6-P (sodium salt), mannose 6-phosphate (disodium salt), glucose, alamethicin, histone IIA, NEM, bovine serum albumin (free fatty acid), and orthovanadate were from Sigma. Mannose, potassium phosphate, PIPES, sucrose, EDTA, beta -mercaptoethanol, ascorbic acid, ammonium molybdate, HEPES, and sodium dodecylsulfate were from Merck.

Preparation of Rat Liver Microsomes-- Fed Wistar rats (220-250 g) were used. Liver microsomes were made as described elsewhere (26). The microsomes were resuspended in a 0.25 M sucrose, 5 mM HEPES buffer, pH 7.4; quickly frozen; and kept at -70 °C until used. The protein concentrations were determined using the Lowry method (27) as modified by Peterson (28) using bovine serum albumin as standard. The intactness of the microsomal vesicles was estimated using the latency of mannose 6-phosphate (29) and was greater than 90% in all the microsomal preparations.

Activity Measurements-- A 96-well microplate assay derived from the colorimetric technique previously described was used (30). The substrates were dissolved at various concentrations in a 24 mM HEPES, 3 mM EDTA buffer, pH 6.5. In some substrate sets, histone IIA at a 1 mg/ml final concentration was added in order to measure the Glc-6-Pase activity in disrupted vesicles (31). In the assay, 5 µl of microsomal suspension were incubated with 25 µl of substrate stock solutions for time periods between 10 and 30 min (depending on the substrate concentration) at 30 °C. Then, 250 µl of a stop solution (0.28% ammonium molybdate, 2.2% SDS, 1.1% ascorbic acid in 0.33 M sulfuric acid) were added in order to measure colorimetrically the amount of phosphate formed. Under our conditions, at least three identical measurements were made, and blanks, in which stop solution was added before the substrates, were used to correct the assay values. A standard curve with known amounts of phosphate was made under identical conditions. The microplates were then incubated at 46 °C for 20 min and read in an ELISA plate reader at 820 nm. The microsomal intactness was measured using 1.67 mM mannose 6-phosphate ± histones. The activity was corrected for intactness using the following equation (32, 33),
<FENCE><UP>SA<SUB>H−</SUB></UP>−<FENCE><UP>M6P<SUB>H−</SUB>/M6P<SUB>H+</SUB></UP></FENCE>×<UP>SA<SUB>H+</SUB></UP></FENCE>/1−<FENCE><UP>M6P<SUB>H−</SUB>/M6P<SUB>H+</SUB></UP></FENCE>=<UP>SA<SUB>intact microsomes</SUB></UP> (Eq. 1)
where SAH- is the Glc-6-Pase specific activity measured without histones, SAH+ is the Glc-6-Pase specific activity measured with histones, and M6PH- and M6PH+ are the activity measured with mannose 6-phosphate as a substrate in absence or presence of histones, respectively.

NEM Chemical Modification-- A 0.25 M stock solution of NEM in sucrose/HEPES buffer, pH 7.4, was prepared by warming up the mixture at 46 °C for 5 min. This solution or dilutions of this stock solution were used to modify rat liver microsomes. In a typical experiment, a pool of microsomal vesicles (1 mg/ml) was incubated in sucrose/HEPES buffer, pH 7.4, at room temperature, in the presence of various concentrations of NEM. Then, at different times, aliquots were withdrawn, and a 2-fold molar excess (with respect to NEM concentration) of beta -mercaptoethanol was added in order to prevent further modification by the alkylating reagent. The samples were kept on ice until assayed for activity or for transport.

Calculations of Inhibition Kinetics-- With nondisrupted microsomes (chemical modification performed in absence of histones), the Glc-6-Pase activity inhibition curves observed were fitted to the following equation (34),
A<SUB><UP>obs</UP></SUB>=A<SUB>1</SUB>e<SUP><UP>−</UP>k1t</SUP>+A<SUB>2</SUB>e<SUP><UP>−</UP>k2t</SUP> (Eq. 2)
where k1 and k2 are the first order rate constants of the quickly and slowly NEM-modified sites, respectively, and t is the time in minutes. The representation ln Aobs = f(time) gave us two straight lines and allowed us to estimate both constant values. k1 and k2 were both found to be NEM concentration-dependent. Consequently, the NEM inhibition was a second order mechanism.

Moreover, and surprisingly, the first order rate constant k1, in contrast to k2, was also dependent on the Glc-6-P concentration used to assay the Glc-6-Pase residual activity. Here, k1 was an apparent constant (k1app). The logarithm of the k1app values was plotted against the Glc-6-P concentration in order to estimate the value of k1 at 0 mM Glc-6-P and is be referred to below as k1extrapolated. For all the NEM concentrations used, values of k1extrapolated and k2 were measured and plotted against the NEM concentration in order to calculate kI and kII, the second-order rate constants of the reactions for the quickly and slowly modified sites, respectively.

For a given NEM concentration, the dependence on Glc-6-P concentrations of k1app values allowed us to estimate the affinity of this compound for the first site modified by NEM using the following relationship,
k1<SUB><UP>extrapolated</UP></SUB>−k1<SUB>x</SUB>/k1<SUB><UP>extrapolated</UP></SUB>−k1<SUB>∞</SUB>=f([<UP>Glc</UP>-6-<UP>P</UP>]) (Eq. 3)
where k1x is the k1app for a Glc-6-P concentration x, and k1infinity equals the k2 value found for the NEM concentration considered. The saturation curve obtained can be linearized via a double reciprocal plot. The intercept with the abscissa axis gave us -1/KD, with KD being the affinity constant of Glc-6-P for the first (quickly) NEM-modified site.

With disrupted microsomes (modification performed in presence of histones), the Glc-6-Pase activity inhibition curves obtained were fitted to the following equation (35),
A<SUB><UP>obs</UP></SUB>=A<SUB>0</SUB>e<SUP><UP>−</UP>kt</SUP> (Eq. 4)
where k is the first order rate constant of the mechanism, A0 is the starting specific activity, and t is the time in minutes. As described previously, k was dependent on the NEM concentration used to inhibit the enzyme activity, indicating that the NEM inhibition of Glc-6-Pase activity in "disrupted" microsomes was also a second order mechanism.

Light Scattering Experiments-- Changes in microsomal vesicle size and shape induced by osmotic modification in the medium were monitored using a Hitachi F-4500 spectrofluorometer equipped with a temperature-controlled cuvette holder (30 °C) and a magnetic stirrer. The mV output signals were acquired at 0.1-s intervals. Both excitation and emission wavelength were 400 nm; the slits were 1 nm for excitation and 5 nm for emission. Stock solutions of sucrose (1 M), Glc-6-P (0.3 M), phosphate (1 M), and glucose (1 M) were prepared in 4 mM PIPES, pH 7.1. NEM-treated and untreated rat liver microsomes were diluted in the same PIPES buffer to a final protein concentration of 0.2 mg/ml. Then, 500 µl of the microsomal vesicle suspension were placed in a cuvette to equilibrate at 30 °C until a stable baseline was obtained. With the use of a Hamilton syringe, 25 µl of substrate stock solutions were added to the cuvette through a hole in the cuvette holder lid. After the trace recovered a baseline level, 5 µl of a 1 mg/ml solution of alamethicin (in ethanol) were added in order to fully permeabilize the microsomes (36-38).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Determination of the NEM Concentration Suitable for Glc-6-Pase Activity Inhibition in "Untreated" (Absence of Histones) Microsomes-- Liver microsomes were incubated in a sucrose/HEPES buffer with different NEM concentrations at room temperature for 1 h and then blocked with beta -mercaptoethanol. Glc-6-Pase activity assayed in nondisrupting conditions started to be inhibited at a NEM concentration higher than 100 µM; the IC50 was 500 µM (not shown). When the activity was measured in NEM-modified vesicles in the presence of histones (permeabilized membranes), the activity loss was very low; the residual activity slightly decreased after 1-2 mM NEM. In the presence or absence of 0.1 mM vanadate, a competitive inhibitor of the Glc-6-Pase catalytic subunit (39), the inhibition in intact vesicles was identical to the control (without vanadate), and when the activity was assayed in the presence of histones, no significant loss of activity was observed (with 1-2 mM NEM concentrations).

NEM Kinetic Inhibition in Untreated Microsomes-- Nondisrupted microsomes in sucrose/HEPES buffer, pH 7.4 (Fig. 2), were incubated at room temperature with various concentrations of NEM (between 0.1 and 1 mM). At different times, an aliquot was withdrawn, and a 2-fold molar excess of beta -mercaptoethanol (with respect to NEM concentration) was added. The microsomal intactness remained unchanged and was between 90 and 95% whatever the NEM concentration and incubation time used (not shown). A logarithmic representation of Glc-6-Pase activity in intact microsomes, modified with 0, 0.25, 0.5, or 1 mM NEM and assayed with 15 mM Glc-6-P as substrate (Fig. 2A), shows two inhibition phases (chemical modification of two different sites), one faster than the other, both of which are dependent on NEM concentration (second order inhibition mechanism).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 2.   Inhibition of Glc-6-Pase activity by NEM in intact microsomes. Microsomes were incubated at room temperature in a sucrose/HEPES buffer, pH 7.4 (identical results were obtained with 4 mM PIPES buffer, pH 7.1). NEM was then added, and at the time indicated in the figure, an aliquot was withdrawn and mixed with a 2-fold excess of beta -mercaptoethanol. The activity was measured using different concentrations of substrate in the absence or presence of histones. A, Glc-6-Pase residual activity was assayed in nondisrupted conditions with 15 mM Glc-6-P as substrate for three sets of NEM-modified rat liver microsomes (open circle , 0; bullet , 0.25; , 0.5; black-triangle, 1 mM). The logarithm of the residual specific activity corrected for intactness is plotted against time. B, the residual specific activity in nondisrupted microsomes modified by 0.5 mM NEM was measured using different concentrations of Glc-6-P (bullet , 0.6; , 2; open circle , 5; black-triangle, 20 mM). The logarithm of the residual specific activity corrected for intactness is plotted against time. C, the same 0.5 mM NEM-treated microsomes were subsequently assayed for activity using the same concentrations of Glc-6-P as reported in B but in the presence of histones (bullet , 0.6; , 2; open circle , 5; black-triangle, 20 mM). The logarithm of the residual specific activity is plotted against time.

Usually, when an irreversible inhibition occurs, whatever the substrate concentration used to measure the activity decrease, the rate constants remain unchanged. From measurements using microsomes modified with a given NEM concentration (0.5 mM in the case of Fig. 2B) and assayed with different concentrations of Glc-6-P, we can observe that, as expected, the second (slow) inhibition phase is not affected by the Glc-6-P concentration used to monitor the residual activity. However the first (fast) phase is greatly accentuated for low concentration of substrate and tends to disappear for high substrate concentrations (>= 20 mM). The k1 rate constants are apparent rate constants (k1app), dependent on substrate concentrations, whereas k2 (rate constant of the second inhibition phase) are not. The activity measured with the same NEM-modified microsomes, which have subsequently been permeabilized by histones, remains constant with time whatever the Glc-6-P concentration used for assaying the residual activity (Fig. 2C).

Kinetic Constants of NEM Modification in Untreated Microsomes-- We calculated the k1app and k2 values for various NEM concentrations. Because k1app values are dependent on the Glc-6-P concentration used to measure the residual activity, we plotted the logarithm base 10 of the k1app values against the Glc-6-P concentration for various NEM concentrations (Fig. 3A). The straight lines obtained allowed us to extrapolate the value of k1app for 0 mM Glc-6-P (k1extrapolated). On the contrary, k2 values were not sensitive to the Glc-6-P concentration (Fig. 3B). The plots of rate constant as a function of inhibitor concentration gave a linear relationship (Fig. 3, C and D), consistent with the idea that NEM was reacting (at each site) with one or a small number of cysteines (if more than one, the modification rates must be very similar). The values of the second order kinetic constant for the quickly (kI) and the slowly (kII) modified sites are 2360 and 33 min-1 M-1, respectively.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Estimation of the second order rate constant of the two NEM inhibition phases. A, from the curve sets (some are shown in Fig. 2, A and B), using the mathematical relation for two category sites each with second order kinetics described under "Experimental Procedures," we calculated the apparent values of the first (fast) phase k1app for each Glc-6-P concentration used for assaying the activity and plotted the log of these values against the Glc-6-P concentration. [NEM]: bullet , 0.25; , 0.5; black-triangle, 1 mM. B, an identical representation was made with the values (k2) calculated for the (slow) inhibition phase. The NEM concentrations used to modify the microsomes were identical to those used in A. C, the values of k1app (A) were extrapolated to 0 mM Glc-6-P. Then, the k1extrapolated values were plotted against the concentration of NEM (second order rate constant kI = 2300 min-1 M-1). D, the second order constant of the second inhibition phase is independent of the Glc-6-P concentration (B). The calculated value of kII is 33 min-1 M-1.

Dissociation Constant Value of Glc-6-P for the First NEM-modified Site-- From the data shown in Fig. 3A, we calculated the dissociation constant between Glc-6-P and the quickly modified site using the relation described under "Experimental Procedures." A saturation curve was obtained (Fig. 4, inset). The double reciprocal representation of the data gives a straight line that allows the calculation of the KD value of Glc-6-P for the fast NEM-modified site. The affinity constant is 2.02 ± 0.26 mM.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Estimation of the affinity constant for Glc-6-P of the first NEM-modified site. From the curves like those shown in Fig. 2A, we calculated the percentage of variation in the first inhibition phase due to Glc-6-P. The Lineweaver-Burk representation shown gives an estimate of the dissociation constant of Glc-6-P for the first NEM-modified site of 2.02 ± 0.26 mM (n = 3; each data point (0) is the average value of the saturation curves obtained with three or four NEM concentrations). The inset presents the saturation curve obtained from the calculation (Equation 3) described under "Experimental Procedures."

Protection by Glc-6-P and Vanadate-- NEM inhibition experiments were performed in the presence of 50 mM Glc-6-P or 100 µM vanadate as described in Table I (legend). The rate constant of the second (slow) NEM-modified site is not dependent on the Glc-6-P concentration used to assay the Glc-6-Pase residual activity. However, when the microsomes were incubated in the presence of both 0.5 mM NEM and 50 mM Glc-6-P, then there was a 2-fold decrease of k2 (p < 0.005 compared with control), showing a protection from NEM (Table I). The k2 was unchanged (not significantly different compared with control) when 100 µM vanadate was added to the microsomes. The first (fast) NEM-modified site rate constant (k1extrapolated) was doubled when the microsomes were incubated with 50 mM Glc-6-P but unchanged (compared with control) when 100 µM vanadate was used (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effect of Glc-6-P and vanadate on Glc-6-Pase activity inhibition by NEM in nondisrupted microsomes
Fed rat liver microsomes (1 mg/ml) were incubated in a 0.25 M sucrose, 5 mM HEPES buffer, pH 7.4, in the absence or the presence of 50 mM Glc-6-P or 100 µM vanadate for 2 min at room temperature. 0.5 mM NEM was then added. At different times, aliquots were withdrawn and a 2-fold molar excess of beta -mercaptoethanol was added. The microsomes were pelleted by centrifugation in order to eliminate the added ligands (Glc-6-P or vanadate). The supernatant was discarded and an equal volume of sucrose/HEPES buffer was used to resuspend the microsomal pellet. Thereafter, the residual specific activity (corrected for intactness) was measured for various Glc-6-P concentrations. From the curves obtained (ln (residual specific activity) = f(time)), we calculated the constant rates of the two inhibition phases (see under "Experimental Procedures"). k2 was in all cases independent of the Glc-6-P concentrations used to assay the residual enzyme activity, whereas k1 was dependent on the Glc-6-P concentration. k1extrapolated values were then determined as described in Fig. 3A. The values of k2 are mean ± S.D. (n = 5).

Effect of NEM on Microsomal Transport of Glc-6-P, Phosphate, and Glucose-- We investigated the transport of both substrate (Glc-6-P) and products (phosphate and glucose) from Glc-6-Pase reaction, in untreated microsomes incubated for various time periods with 1 mM NEM (Fig. 5). Typical traces are presented for sucrose (Fig. 5a), a nonpermeating compound, Glc-6-P (Fig. 5b), phosphate (Fig. 5c), and glucose (Fig. 5d) with microsomes incubated with 2 mM beta -mercaptoethanol. The same type of traces are shown for microsomes treated for 1 h with 1 mM NEM and in which 2 mM beta -mercaptoethanol was added in order to stop the NEM alkylation reaction (Fig. 5, e-h). Traces for sucrose (Fig. 5e), phosphate (Fig. 5g), and glucose (Fig. 5h) were identical to those obtained in normal (no NEM) microsomes (Fig. 5, a, c, and d). The Glc-6-P transport traces obtained with 1 mM NEM-treated microsomes for 2, 20, 30, and 60 min are shown in Fig. 5f. In that case, both half-lives and light scattering variations (from the top of the trace to the recovered baseline; see Fig. 5h, double arrow line) are modified. To monitor the NEM modification of the different transport systems, we chose to use the light scattering variation (as shown in Fig. 5h) as a parameter reflecting the percentage of microsomal vesicles still exhibiting transport. Then we plotted the logarithm of these values against time for the three different transport systems (Fig. 6). The phosphate and glucose transport were not affected by NEM-microsome alkylation. However, Glc-6-P transport was reduced in a first order manner. The value of the inhibition rate constant (0.025 min-1) is not significantly different from the value of the rate constant obtained from Glc-6-Pase activity measurements with the same NEM-treated microsomes: 0.028 min-1 (corresponds to the second inhibition phase rate constant, k2).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 5.   Influx of various compounds into liver microsomal vesicles modified or not with 1 mM NEM evaluated by a light scattering technique. Liver microsomes (1 mg/ml) were modified with 1 mM NEM in 4 mM PIPES, pH 7.1. At various times, aliquots were withdrawn and NEM modification was stopped by adding 2 mM beta -mercaptoethanol. During this procedure, microsomes were kept on ice and, before being used for light scattering experiments, were diluted 5-fold (in 4 mM PIPES, pH 7.1). Osmotically induced changes in microsomal vesicle size and shape were induced by addition of 25 µl (black arrowhead) (in a microsome volume of 500 µl) of 4 mM PIPES (a, bottom trace) or of concentrated solutions of sucrose (a and e), Glc-6-P (b and f), phosphate (c and g), and glucose (d and h), leading to final concentrations of 50, 15, 50, and 50 mM, respectively. Alamethicin was added to fully permeabilize the microsomal vesicles (open arrowhead). Traces are representations of two separate experiments: traces a, b, c, and d were observed with untreated microsomes, and traces e, f, g, and h were observed with 1 mM NEM-modified microsomes (e, g, and h, 60-min incubation; f, 2, 20, 30, and 60 min incubation). In h, the double arrow line shows a light scattering variation that is proportional to the number of microsomal vesicles transporting the substrate.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 6.   Evidence that translocase for Glc-6-P transport but not for phosphate or glucose is affected by NEM modification. The traces (some are shown in Fig. 5) obtained both with substrate (15 mM Glc-6-P) and products (50 mM phosphate and 50 mM glucose) of Glc-6-Pase reaction were analyzed as follows. The light scattering intensity variations, comprising the difference between the top of the trace (initiation of the transport) and the recovered baseline (when the compound concentrations outside and inside the vesicles are presumed to be identical) were measured (see double arrow in Fig. 5h) and normalized to the value obtained for time 0. We assumed that these values are proportional to the number of microsomal vesicles that are still able to exhibit transport (i.e. to the number of still functional transporters). We plotted the logarithm of these values against time. Each point is the average of two separate experiments (open circle , Glc-6-P; triangle , phosphate; black-square, glucose).

Determination of the NEM Concentration Suitable for Glc-6-Pase Inhibition in Disrupted Microsomes-- Liver microsomes (1 mg/ml) previously permeabilized for 30 min with 1 mg/ml of histones were incubated at room temperature with various amounts of NEM. After 1 h, a 2-fold excess (over NEM) of beta -mercaptoethanol was added to prevent further modification. The residual Glc-6-Pase specific activity was assayed using 20 mM Glc-6-P and plotted against NEM concentration (not shown). Inhibition of Glc-6-Pase activity was observed for NEM concentration values higher than 1-2 mM and is maximal for concentrations over 20-25 mM. The IC50 measured in these conditions was 7-8 mM.

NEM Kinetic Inhibition in "Disrupted" Microsomes-- Disrupted microsomes were subjected to different concentrations of NEM and then assayed for residual Glc-6-Pase activity with different concentrations of Glc-6-P. The activities were normalized to the value obtained for time 0 and plotted against time (Fig. 7A). The figure shows that there was no effect (within the experimental error) of Glc-6-P concentration on the inhibition rate constant for a given NEM concentration. Moreover, the NEM inhibition is a pseudo-first order mechanism with one modified site. The second-order rate constant was calculated plotting the first order rate constant against NEM concentration; its value is 1.1 min-1 M-1 (see Fig. 7A, inset). A protection experiment with a broad range of substrates and products of Glc-6-Pase catalytic subunit from NEM inhibition is presented in Fig. 7B. All of the compounds tested had a protection effect. We must note that glucose and mannose can both protect, but only if they are used at a high concentration (>200-250 mM), which is in agreement with the dissociation constant of these two sugars with the Glc-6-Pase catalytic subunit (40).


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 7.   Chemical modification by NEM of Glc-6-Pase in disrupted microsomes. The microsomes (1 mg/ml) were treated as described under "Experimental Procedures." A, representation of the logarithm of the normalized residual specific activity against time (assuming that the activity at time 0 = 1). The NEM concentrations used were 2 (bullet ), 10 (diamond ), 20 (black-square), and 30 (open circle ) mM. A stability control without NEM was also performed (). The Glc-6-P concentrations used to assay the activity were 0.2, 0.4, 0.6, 2 and 10 mM. In the inset, the slopes of the straight lines obtained in A were plotted against NEM concentration to give a second order constant value of 1.1 min-1.M-1. B, the effect of substrates on NEM modification. The microsomes (1 mg/ml) were incubated with 30 mM NEM by itself (open circle ) and with 30 mM Glc-6-P (black-diamond ), 30 mM mannose 6-phosphate (triangle ), 30 mM phosphate (black-triangle), 300 mM glucose (), 300 mM mannose (diamond ), or 0.1 mM vanadate (bullet ). A stability control without NEM was also carried out (black-square). In order to eliminate the substrates, the microsomes were centrifuged at 30,000 × g for 30 min at 4 °C, the supernatant was discarded, and the pellet was resuspended in the previous volume of sucrose/HEPES buffer. The residual specific activity was then measured using 10 mM Glc-6-P. The logarithm of the normalized residual activity (activity for time 0 = 1) is plotted against time.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

NEM is a relatively specific sulfhydryl reagent commonly used to assess the structure of proteins (35, 41, 42). We have to note that reactions with amino groups can occur (43, 44) but need high pH conditions (>8.5-9.0). NEM can cross phospholipid membranes. Thus, studying the topology of a membrane protein using only this reagent is difficult. However in our case, the high reactivity of this compound toward cysteine residues makes it a good tool to examine the structure of the liver microsomal Glc-6-Pase system.

Relatively low concentrations of NEM (<1-2 mM) inhibited the activity of the Glc-6-Pase system when microsomes were incubated in nondisrupting conditions. However, when the membrane was subsequently treated with histones, the activity measured was identical to those of the NEM-unmodified controls (Fig. 2C), showing that the catalytic subunit activity is not affected by an alkylation by 1-2 mM NEM of one or more of its cysteine residues. When an inhibition time course is made in nondisrupted microsomes (Fig. 2, A and B), a two site (two different thiol groups), first order kinetic inhibition is demonstrated; the first site was modified after only 2 min, and the second site needed more time to be alkylated by NEM. The modification rate of the two sites depends on NEM concentration (Fig. 2A). The rate constant for the second modified site was unchanged, whatever the Glc-6-P concentration used to assay the residual activity (Figs. 2B and 3B), but surprisingly, the rate constant of the first modified site depends on the substrate concentration used to determine residual activity (Figs. 2B and 3A). Indeed, the inhibition was released when the concentration of Glc-6-P used was higher than 20 mM (Figs. 2B and 3A). Here in the first phase, the rate constants (k1) are apparent constants. An extrapolation of the k1app to 0 mM Glc-6-P has been done to calculate the second order constant of the reaction. The value of the second order rate constant kI for the first (quickly) modified thiol is 2360 min-1 M-1 (Fig. 3C), whereas the calculated value for the second site is 33 min-1 M-1.

A light scattering technique (36) has demonstrated that the Glc-6-P translocase was the only transporter inhibited by NEM alkylation (Figs. 5 and 6) and that the Glc-6-P transport inhibition was closely correlated to the activity loss. Therefore, the two thiol groups, modified with different velocities, are in the T1 protein.

The extent of inhibition due to the NEM alkylation of the T1 first reactive site depends on the Glc-6-P concentration used to assay the residual activity (Fig. 2B). This dependence is a saturation process (Fig. 4). We explain the effect of Glc-6-P on the first inhibition phase by the binding of this compound to T1, which causes a conformational change releasing the effects of NEM modification. Whether this Glc-6-P molecule is regulatory and/or transported is still unclear. In 1991, Nordlie and co-workers reported that T1 could be regulated by intramicrosomal levels of Glc-6-P (45). The conformational change observed in our conditions could be the reflection of such a regulation.

Protection experiments, performed with nondisrupted vesicles in the presence of Glc-6-P or vanadate, have shown that vanadate has no effect on the inhibition process (Table I). However, a high concentration of Glc-6-P, the transported compound, partially prevents the second site from NEM modification and increases the reactivity of the first site, by improving its accessibility to NEM. From these observations, it seems that two areas or domains, each containing a reactive cysteine residue, can be found in T1. A description of their particular features is attempted in the working model proposed in Fig. 8.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 8.   Model of Glc-6-P translocase states during its modification by NEM. T1 is represented as a two domain protein, with each domain containing an NEM-modifiable cysteine residue. The protein can be found in two interconvertible states (I and I'), with Glc-6-P being the ligand that allows their interconversion. In the state I', the first (fast) NEM-alkylated site is even more reactive (more accessible) than in state I, whereas the second (slow) site is less reactive (buried) than in state I. Then, when the NEM alkylation occurs, the number of transporter molecules modified at the first site will be higher in the presence of Glc-6-P. The modification of the first site has an inhibitory effect that can be released by using high concentrations of Glc-6-P (II right-arrow II'). Therefore, at high substrate concentrations, Glc-6-Pase system activity loss in the assay with NEM alone is similar to that in the presence of 50 mM Glc-6-P. However, for longer incubation times, the second site, which can be partially protected by Glc-6-P, is more modified in the conditions where NEM is used alone (III and III'). The states III and III' are inactive even though high concentrations of Glc-6-P are used to assay the residual activity.

Recently, a human membrane protein that exhibits sequence similarities with bacterial phosphoester transporters, such as UhpT (the sugar phosphate carrier of Escherichia coli), and that is mutated in patients suffering from glycogen storage disease 1b (no Glc-6-P transport), has been cloned (46). In bacteria, two UhpT cysteines can be modified by sulfhydryl reagents leading to an inactive protein (47, 48). The behavior of the mammalian T1 reported in this paper is rather close to that observed with UhpT. Hence, it seems possible that the putative Glc-6-P translocase recently cloned is T1.

Experiments performed with histone-disrupted microsomes allow us to look directly at the effects of NEM on the Glc-6-Pase catalytic subunit activity without the rate limitations imposed by the translocases. The catalytic subunit loses its activity at NEM concentration higher than those used to inhibit the whole system in nondisrupting conditions (IC50 = 7-8 mM instead of 0.5 mM). The incubation of the histones with dithionitrobenzoate (Ellman's reagent) did not result in a yellow coloration mark of titrable cysteines. Thus, the higher IC50 cannot be attributed to the presence of cysteines in the histones. We therefore have to assume that a thiol group of the Glc-6-Pase catalytic subunit can be modified but needs rather high NEM concentrations.

The NEM inhibition of the Glc-6-Pase catalytic subunit (Fig. 7A) is a second order mechanism (k = 1.1 min-1 M-1).The presence of substrates in the NEM incubation assay fully protects the enzyme from the inhibition, which suggests that the modified cysteine is located in the protein active site or that substrate binding hides the thiol group via a conformational change in the Glc-6-Pase structure. The identification of the residue alkylated by NEM would be helpful for completing the recently proposed Glc-6-Pase topology (49, 50) and improving our knowledge of the Glc-6-Pase active site.

    ACKNOWLEDGEMENT

We thank Dr. Peter E. Ross for access to his Hitachi spectrofluorometer.

    FOOTNOTES

* This work was supported by grants from the Medical Research Council and the Royal Society (to A. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 44-1382-632445; Fax.: 44-1382-633847; E-mail: aburchell{at}ninewells.dundee.ac.uk.

1 The abbreviations used are: Glc-6-P, glucose-6-phosphate; Glc-6-Pase, glucose-6-phosphatase; NEM, N-ethylmaleimide; PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid).

2 Glc-6-Pase sequence from fish: S. Nagl, W. E. Mayer, and J. Klein, GenBankTM accession number AF008945.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Nordlie, R. C., and Sukalski, K. A. (1985) in The Enzymes of Biological Membranes (Martonosi, A. N., ed), Vol. 2, pp. 349-398, Plenum Publishing Corp., New York
  2. Countaway, J. L., Waddell, I. D., Burchell, A., and Arion, W. J. (1988) J. Biol. Chem. 263, 2673-2678[Abstract/Free Full Text]
  3. Burchell, A., Waddell, I. D., Countaway, J. L., Arion, W. J., and Hume, R. (1988) FEBS Lett. 242, 153-156[CrossRef][Medline] [Order article via Infotrieve]
  4. Wada, N., and Chou, J. Y. (1993) J. Biol. Chem. 268, 14003-14010[Abstract/Free Full Text]
  5. Lei, K.-J., Shelly, L. L., Pan, C.-J., Sidbury, J. B., and Chou, J. Y. (1993) Science 262, 580-583[Medline] [Order article via Infotrieve]
  6. Lange, A. J., Argaud, D., El-Maghrabi, M. R., Pan, W., Maitra, S. R., and Pilkis, S. J. (1994) Biochem. Biophys. Res. Commun. 201, 302-309[CrossRef][Medline] [Order article via Infotrieve]
  7. Kishnanni, P. S., Bao, Y., Wu, J.-Y., Brix, A. E., Lin, J.-L., and Chen, Y.-T. (1997) Biochem. Mol. Med. 61, 168-177[CrossRef][Medline] [Order article via Infotrieve]
  8. Nordlie, R. C. (1976) in Glucogneogenesis: Its Regulation in Mammalian Species (Hanson, R. W., ed), pp. 93-152, John Wiley & Sons, New York
  9. Arion, W. J., Carlson, P. W., Wallin, B. K., and Lange, A. J. (1972) J. Biol. Chem. 247, 2551-2557[Abstract/Free Full Text]
  10. Stetten, M. R., and Burnett, F. F. (1967) Biochim. Biophys. Acta 139, 138-147[Medline] [Order article via Infotrieve]
  11. Shulze, H. U., Nolte, B., and Kannler, R. (1986) J. Biol. Chem. 261, 16571-16578[Abstract/Free Full Text]
  12. Arion, W. J., Wallin, B. K., Lange, A. J., and Ballas, L. M. (1975) Mol. Cell. Biochem. 6, 75-83[Medline] [Order article via Infotrieve]
  13. Arion, W. J., Lange, A. J., Walls, H. E., and Ballas, L. M. (1980) J. Biol. Chem. 255, 10396-10406[Abstract/Free Full Text]
  14. Nordlie, R. C. (1974) Curr. Top. Cell Regul. 8, 33-117[Medline] [Order article via Infotrieve]
  15. Zakim, D., and Dannenberg, A. (1990) J. Biol. Chem. 265, 201-208[Abstract/Free Full Text]
  16. Berteloot, A., Vidal, H., and van de Werve, G. (1991) J. Biol. Chem. 266, 5497-5507[Abstract/Free Full Text]
  17. St Denis, J. F., Comte, B., Nguyen, D. K., Seidman, E., Paradis, K., Levy, E., and van de Werve, G. (1994) J. Clin. Endocrinol. Metab. 79, 955-959[Abstract]
  18. Berteloot, A., St-Denis, J.-F., and van de Werve, G. (1995) J. Biol. Chem. 270, 21098-21102[Abstract/Free Full Text]
  19. Burchell, A. (1992) BioEssays 14, 395-400[Medline] [Order article via Infotrieve]
  20. Arion, W. J., Canfield, W. K., Callaway, E. S., Burger, H.-J., Hemmerler, H., Schubert, G., Herling, A. W., and Oekonomopulos, R. (1998) J. Biol. Chem. 273, 6223-6227[Abstract/Free Full Text]
  21. Wallin, B. K., and Arion, W. J. (1972) Biochem. Biophys. Res. Commun. 48, 694-699[Medline] [Order article via Infotrieve]
  22. Colilla, W., and Nordlie, R. C. (1973) Biochim. Biophys. Acta 309, 328-338[Medline] [Order article via Infotrieve]
  23. Valkili, B., and Banner, M. (1981) Biochem. J. 194, 319-325[Medline] [Order article via Infotrieve]
  24. Arion, W. J., Schulz, L. O., Lange, A. J., Telford, J. N., and Walls, H. E. (1983) J. Biol. Chem. 258, 12661-12669[Abstract/Free Full Text]
  25. Garland, R. C., Cori, C. F., and Chang, H. F. W. (1976) Mol. Cell. Biochem. 12, 23-31[Medline] [Order article via Infotrieve]
  26. Arion, W. J., Burchell, B., and Burchell, A. (1984) Biochem. J. 220, 835-842[Medline] [Order article via Infotrieve]
  27. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275[Free Full Text]
  28. Peterson, G. L. (1973) Anal. Biochem. 83, 346-356
  29. Arion, W. J., Ballas, L. M., Lange, A. J., and Wallin, B. K. (1976) J. Biol. Chem. 251, 4901-4907[Abstract/Free Full Text]
  30. Burchell, A., Hume, R., and Burchell, B. (1988) Clin. Chim. Acta 173, 183-191[CrossRef][Medline] [Order article via Infotrieve]
  31. Blair, J. N., and Burchell, A. (1988) Biochim. Biophys. Acta 964, 161-167[Medline] [Order article via Infotrieve]
  32. Arion, W. J., Lange, A. J., and Walls, H. E. (1980) J. Biol. Chem. 255, 10387-10395[Free Full Text]
  33. Lange, A. J., Arion, W. J., and Beaudet, A. L. (1980) J. Biol. Chem. 255, 8381-8384[Free Full Text]
  34. Hill, B. C., and Peterson, J. (1998) Arch. Biochem. Biophys. 350, 273-282[CrossRef][Medline] [Order article via Infotrieve]
  35. Petrov, V. V., Pardo, J. P., and Slayman, C. W. (1997) J. Biol. Chem. 272, 1688-1693[Abstract/Free Full Text]
  36. Meissner, G. (1988) Methods Enzymol. 157, 417-437[Medline] [Order article via Infotrieve]
  37. Fulceri, R., Bellomo, G., Gamberucci, A., Scott, A., Burchell, A., and Benedetti, A. (1992) Biochem. J. 286, 813-817[Medline] [Order article via Infotrieve]
  38. Marcolongo, P., Fulceri, R., Giunti, R., Burchell, A., and Benedetti, A. (1996) Biochem. Biophys. Res. Commun. 219, 916-922[CrossRef][Medline] [Order article via Infotrieve]
  39. Singh, J., Nordlie, R. C., and Jorgenson, R. A. (1981) Biochim. Biophys. Acta 678, 477-482[Medline] [Order article via Infotrieve]
  40. Arion, W. J., Ballas, L. M., Lange, A. J., and Wallin, B. K. (1976) J. Biol. Chem. 251, 4891-4897[Medline] [Order article via Infotrieve]
  41. Kimura, T., Ohnuma, M., Sawai, T., and Yamaguchi, A. (1997) J. Biol. Chem. 272, 580-585[Abstract/Free Full Text]
  42. Woltjer, R. L., and Staros, J. V. (1997) Biochemistry 36, 9911-9916[CrossRef][Medline] [Order article via Infotrieve]
  43. Brewer, C. F., and Riehm, J. P. (1967) Anal. Biochem. 18, 248-255
  44. Knight, P., and Offer, G. (1978) Biochem. J. 175, 1023-1032[Medline] [Order article via Infotrieve]
  45. Foster, J. D., Nelson, K. L., Sukalski, K. A., Lucius, R. W., and Nordlie, R. C. (1991) Biochim. Biophys. Acta 1118, 91-98[Medline] [Order article via Infotrieve]
  46. Gerin, I., Veiga-da-Cunha, M., Achouri, Y., Collet, J.-F., and Van Schaftingen, E. (1997) FEBS Lett. 419, 235-238[CrossRef][Medline] [Order article via Infotrieve]
  47. Yan, R. T., and Maloney, P. C. (1993) Cell 75, 37-44[Medline] [Order article via Infotrieve]
  48. Yan, R. T., and Maloney, P. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5973-5976[Abstract/Free Full Text]
  49. Hemricka, W., and Wever, R. (1997) FEBS Lett. 409, 17-19[CrossRef][Medline] [Order article via Infotrieve]
  50. Pan, C.-J., Lei, K.-J., Annabi, B., Hemrika, W., and Chou, J.-Y. (1998) J. Biol. Chem. 273, 6144-6148[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.